Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP134056.RADnTQy8y3-vk1HeaUpncJ1cPxJ56KwqhlKUaIC60fuiM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP134056.RADnTQy8y3-vk1HeaUpncJ1cPxJ56KwqhlKUaIC60fuiM130_assertion type Assertion NP134056.RADnTQy8y3-vk1HeaUpncJ1cPxJ56KwqhlKUaIC60fuiM130_head.
- NP134056.RADnTQy8y3-vk1HeaUpncJ1cPxJ56KwqhlKUaIC60fuiM130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP134056.RADnTQy8y3-vk1HeaUpncJ1cPxJ56KwqhlKUaIC60fuiM130_provenance.
- NP134056.RADnTQy8y3-vk1HeaUpncJ1cPxJ56KwqhlKUaIC60fuiM130_assertion evidence source_evidence_literature NP134056.RADnTQy8y3-vk1HeaUpncJ1cPxJ56KwqhlKUaIC60fuiM130_provenance.
- NP134056.RADnTQy8y3-vk1HeaUpncJ1cPxJ56KwqhlKUaIC60fuiM130_assertion SIO_000772 17342071 NP134056.RADnTQy8y3-vk1HeaUpncJ1cPxJ56KwqhlKUaIC60fuiM130_provenance.
- NP134056.RADnTQy8y3-vk1HeaUpncJ1cPxJ56KwqhlKUaIC60fuiM130_assertion wasDerivedFrom lhgdn-20090331 NP134056.RADnTQy8y3-vk1HeaUpncJ1cPxJ56KwqhlKUaIC60fuiM130_provenance.
- NP134056.RADnTQy8y3-vk1HeaUpncJ1cPxJ56KwqhlKUaIC60fuiM130_assertion wasGeneratedBy ECO_0000203 NP134056.RADnTQy8y3-vk1HeaUpncJ1cPxJ56KwqhlKUaIC60fuiM130_provenance.